Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » CRISPR Screen Identifies Host Genes Needed for SARS-CoV-2 Infection, Potential Drug Targets

CRISPR Screen Identifies Host Genes Needed for SARS-CoV-2 Infection, Potential Drug Targets

Oct 26, 2020
|
staff reporter

NEW YORK – A CRISPR-based loss-of-function screen has identified host genes that are needed for SARS-CoV-2 to infect human lung cells, pointing to potential novel treatment targets for COVID-19.

SARS-CoV-2 has infected more than 40 million people worldwide, leading to more than 1 million deaths. While a number of vaccines against SARS-CoV-2 are in clinical trials, others are looking for potential therapeutics to treat COVID-19.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Infectious Disease

  1. CDC Advises Avoiding Holiday Travel, Using SARS-CoV-2 Testing to Mitigate Risk During COVID-19 Surge

  2. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

  3. Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

  4. TNG Dx, Premier Medical Laboratories Partner to Develop RNA Extraction Protocol for COVID-19 Tests

  5. Canadian Consortium Launches COVID Cloud to Support Molecular Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.